The Christ Hospital Health Network is proud to welcome Rod Flynn, MD. Dr. Flynn is a surgical oncologist and brings extensive experience and a new treatment focus to The Christ Hospital Health Network-Hyperthermic Intraperitoneal Chemotherapy (HIPEC), a highly concentrated, heated chemotherapy treatment that is delivered directly to the abdomen during surgery. Unlike systemic chemotherapy delivery, which circulates through the body, HIPEC delivers chemotherapy directly to cancer cells in the abdomen. Advantages of HIPEC include: allows for high doses of chemotherapy, enhances and concentrates chemotherapy within the abdomen, minimizes the rest of the body’s exposure to the chemotherapy, improves chemotherapy absorption and susceptibility of cancer cells and reduces some chemotherapy side effects. HIPEC gives patients with specific types of advanced cancer hope who were otherwise resigned to hospice.

Dr. Flynn earned his medical degree at University of Maryland School of Medicine and completed his residency at the Graduate Hospital. He completed a surgical oncology fellowship at University of Pittsburgh Medical Center. He worked at hospitals in Maryland and Virginia and most recently built and led the HIPEC program at Cancer Treatment Centers of America in Philadelphia.